Insider Buys
This tool is in beta, validation in progress.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Risk Factors Update Summary
- We will need additional funding and may be unable to raise capital, delaying or eliminating research activities.
- The regulatory approval processes of the FDA are lengthy and unpredictable, potentially preventing product revenue generation.
- Changes in funding for the FDA and SEC could hinder their functions, negatively impacting our business operations.
- Material modifications in manufacturing methods may result in additional costs or delays, impacting product candidate commercialization.
- We are highly dependent on key personnel; failure to attract and retain them may harm our business strategy.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1314052&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.